Axillary dissection is avoidable in most cT1N0 triple‑negative & HER2+breast cancers treated with upfront surgery Por Kati Axillary dissection is avoidable in most cT1N0 triple‑negative & HER2+breast cancers treated with upfront surgery Read More »
A-BRAVE trial: a Phase 3 randomized trial with anti-PD-L1 avelumab in high-risktriple-negative early breast cancer patients Por Kati A-BRAVE trial: a Phase 3 randomized trial with anti-PD-L1 avelumab in high-risktriple-negative early breast cancer patients Read More »
Axillary surgery in early breast cancer: real-world analysis of theINSEMA-trial at three certified university breast cancer centers in Germanyregarding the omission of sentinel lymph node biopsy Por Kati Axillary surgery in early breast cancer: real-world analysis of theINSEMA-trial at three certified university breast cancer centers in Germanyregarding the omission of sentinel lymph node biopsy Read More »
Impact of a Weight Loss Intervention on 1-Year Weight Changein Women With Stage II/III Breast Cancer Por Kati Impact of a Weight Loss Intervention on 1-Year Weight Changein Women With Stage II/III Breast Cancer Read More »
The impact of radiotherapy on trials of axillary management in early breastcancer Por Kati The impact of radiotherapy on trials of axillary management in early breastcancer Read More »
Brain Imaging Surveillance for Patients With MetastaticBreast Cancer: A Randomized Clinical Trial Is Requiredto Guide Practice Por Kati Brain Imaging Surveillance for Patients With MetastaticBreast Cancer: A Randomized Clinical Trial Is Requiredto Guide Practice Read More »
The Role of Axillary Lymph NodeDissection in Breast Cancer PatientsWith Residual Nodal Disease AfterReceiving Neoadjuvant Chemotherapy Por Kati The Role of Axillary Lymph NodeDissection in Breast Cancer PatientsWith Residual Nodal Disease AfterReceiving Neoadjuvant Chemotherapy Read More »
Extending the duration of endocrine treatment for earlybreast cancer: patient-level meta-analysis of 12 randomisedtrials of aromatase inhibitors in 22031 postmenopausalwomen already treated with at least 5 years of endocrinetherapy Por Kati Extending the duration of endocrine treatment for earlybreast cancer: patient-level meta-analysis of 12 randomisedtrials of aromatase inhibitors in 22031 postmenopausalwomen already treated with at least 5 years of endocrinetherapy Read More »
Do regularly scheduled visits result in earlier detection of curablebreast cancer recurrences? Por Kati Do regularly scheduled visits result in earlier detection of curablebreast cancer recurrences? Read More »
Hormonal factors predictive of fertility in patients with breast cancerinterrupting adjuvant endocrine therapy to attempt pregnancy inPOSITIVE trial Por Kati Hormonal factors predictive of fertility in patients with breast cancerinterrupting adjuvant endocrine therapy to attempt pregnancy inPOSITIVE trial Read More »
Long-Term Locoregional Outcomes in a Contemporary Cohortof Young Women With Breast Cancer Por Kati Long-Term Locoregional Outcomes in a Contemporary Cohortof Young Women With Breast Cancer Read More »
Efficacy of targeting high mean arterial pressure for older patients with septic shock (OPTPRESS): a multicentre, pragmatic, open-label, randomised controlled trial Por Adson Machado Efficacy of targeting high mean arterial pressure for older patients with septic shock (OPTPRESS): a multicentre, pragmatic, open-label, randomised controlled trial Read More »
